Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil - Launay, D; Sitbon, O; Le Pavec, J (Rheumatology (Oxford), 2010)
, et al.